Combiphar has since continued to touch the lives of the Indonesian people. Today, more and more individuals and families are feeling the benefits from Combiphar’s products and healthy lifestyle educations. Today, Combiphar produces and distributes more than 80 affordable prescription and over-the-counter drugs to its consumers, including OBH Combi cough syrup and Insto eye drops. The various brands of medication produced and marketed by Combiphar each contribute an important role in their respective categories. Numerous initiatives to support various communities and professional medical practitioners have also been introduced as Combiphar’s commitment to the health of the nation.
Combiphar starting international business in 2016 with Eye Mo in The Philippine. Currently Combiphar already presence in Asia i.e Philippine, Malaysia, Singapore, Cambodia, Hong Kong, Brunei Darussalam, Macau, Taiwan, Vietnam, China, Fiji Islands, and South Korea. We are also presence in UAE, Oman, Maldives, Kenya, Somalia and Niger. In the future, Combiphar will continue to expand in international market.
Becoming the prominent healthcare company that touches the life of the stakeholders through individual and community well-being improvement.
• Elevating stakeholders well-being through promoting product with excellent quality • Promoting healthy lifestyle • Providing added values and benefits for all stakeholders
Consumer-focused solution • Uphold Integrity • Innovation • Enthusiasm • Cooperation • Synergy & Harmony
Melakukan produksi komersial perdana obat tetes mata INSTO dari fasilitas pabrik terbaru di Cikarang. Pabrik ini mampu menampung kapasitas produksi hingga 50 juta botol per tahun dan masih dapat dikembangkan lagi. - Pengambilalihan Saham Akuisisi Simba Indosnack Makmur
In 2019, Combiphar acquired Air Mancur Group to affirm the commitment of Championing a Healthy Tomorrow, by expanding the Combiphar product line to help create a healthier generation of Indonesia. Combiphar Entering Hong Kong
Under the wings of Anugerah Group, Combiphar collaborates with leading pharmaceutical companies in more than 19 countries. From this collaboration, Combiphar regularly carries out quality control audits, get trained and knowledge by international caliber partners to improve quality. Combiphar Entering Singapore and Malaysia. 2016, Eye Mo Acquisition from GSK. Combiphar Entering 1st international market, Philippine. 2018, Combiphar Entering Cambodia.
ISO 9001-2000 Certification, R & D Facilities Upgrade, Implement Lean Manufacturing
New Head Office Relocation and New Corporate Identity Launch
CSR Program Launch - Combi Hope Healthy Living Education & Women’s Empowerment INSTO Brand Acquisition Combi Care Centre Launch
Affordable and High Quality Products
Consumer Dialogue and Engagement
Build and Educate Communities